Skip to main content
. 2019 Nov 22;14:2563–2573. doi: 10.2147/COPD.S219821

Table 1.

Clinical Characteristics Of Patients With Clinically Stable Bronchiectasis And Healthy Subjects

Parameter Bronchiectasis Patients Healthy Subjects P value
No. of subjects 82 9
PA colonization (No., %) 34 (41.5%) NA NA
Anthropometry
 Age (years) 45.4±14.0 45.8±16.5 0.352
 Females (No., %) 49 (59.8%) 4 (44.4%) 0.483
 Body-mass index (kg/m2) 20.2±2.8 22.6±2.0 0.432
 Never-smokers (No., %) 6 (7.3%) 1 (11.1%) 0.530
FEV1 predicted% 57.7±22.3 95.4±8.8 <0.001
Exacerbation history
 No. of exacerbations within 1 yr 1.4±1.1 NA NA
Severity
 Bronchiectasis Severity Index 6.6±4.0 NA NA
 E-FACED score 3.7±1.9 NA NA
 Modified Reiff score 9.8±4.1 NA NA
Aetiology
 Idiopathic (No., %) 25 (30.5%) NA NA
 Post-infectious (No., %) 33 (40.2%) NA NA
 Kartagener syndrome (No., %) 8 (9.8%) NA NA
 Asthma (No., %) 2 (2.4%) NA NA
 Immunodeficiency (No., %) 5 (6.1%) NA NA
 GORD-aspiration (No., %) 4 (4.8%) NA NA
 Others (No., %)a 7 (8.5%) NA NA
Bacteria isolated during the initial visit
Pseudomonas aeruginosa 36 (43.9%) NA NA
Haemophilus influenzae 9 (11.0%) NA NA
Escherichia coli 4 (4.9%) NA NA
 Other pathogensb 7 (8.5%) NA NA
 Commensal 26 (31.7%) NA NA
Sputum physical characteristic
 Viscosity score 2.5±0.7 2.3±0.9 0.747
 Purulence score 6.2±0.9 4.0±0.5 <0.001

Notes: P-value for comparisons between patients with clinically stable bronchiectasis and healthy subjects. Othersa included congenital airway defects, diffuse panbronchiolitis and connective tissue disease. bOther pathogens included Klebsiella pneumiae, Proteus mirabilis, Streptococcus pneumoniae, Haemophilus parainfluenzae, Haemophilus parahaemolyticus, Sphingomonas sphingomonas, Enterobacter aerogenes.

Abbreviations: E-FACED, exacerbation-FACED; GORD, gastroesophageal reflux disease-aspiration.